81 - 90 of 145 Results
Microbial/ fungal infection is one of the most serious complications in hospitals, medical devices, drugs, health care and hygienic applications, water purification systems, and dental surgery equipment, textiles, food packaging, and food storage.
One synthetic platform technologies for nanomaterials at ORNL, “NanoFermentation (NF)”, can be defined as “A biomineralization process using microbial activity (respiration or fermentation) as a driving force to focus on both quality and quantity of nanoparticle production
As biofuel production from cellulosic sugars increases, there is an increasing need for technologies that add value to lignin-rich streams. Isobutene is a high value, large market chemical.
PtCAD2359 is a key regulator of lignin biosynthesis. Changes in expression levels can result in altered cell wall chemistry.
The invention relates to vaccine storage and more specifically to a device for maintaining vaccines at reduced temperature during transport and dissemination to patients.
A sustainable future will likely be dependent on large-scale production of fuels, chemicals, and products from renewable resources. One of the most promising approaches to this end is microbially-synthesized bioproducts from plant sugars.
Our invention allow for multiple DNA fragments, inserted in a plasmid DNA, to be combined in a one-pot reaction without previous manipulation of the input DNAs (as by polymerase chain reaction linearization or gel-purification of digested fragments) with an efficient exchange
This disclosure describes the use of novel Silicon-based antioxidants for aiding in the repair and regeneration of bone. Bone injuries are problematic to heal because they heal in three steps.
Current pathways to generate biofuels either ferment sugars derived from biomass or convert them to a partially-oxygenated intermediate to be reduced to higher density fuels.
The invention relates to the medical industry and more specifically to methods of predicting risks.